Imprinted polymeric NANO materials for the purification and determination of methamphetamine or amphetamine and synthesis method thereof
A molecularly imprinted polymeric nanomaterial with L-tryptophan functional monomer enhances MeA and AMP purification efficiency, addressing industrial inefficiencies by enabling single-step high-purity purification and reuse, suitable for diagnostic and biosensor applications.
Patent Information
- Application Number
- PCT/TR2025/051589
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-12-05
- Publication Date
- 2026-07-02
AI Technical Summary
Current methods for purifying methamphetamine (MeA) and amphetamine (AMP) in industrial settings are time-consuming, costly, and inefficient, requiring complex equipment and multiple analyses, with potential loss of product and reduced yields due to retention in columns and solvent use.
Development of a molecularly imprinted polymeric nanomaterial with high affinity for MeA and AMP, allowing single-step chromatographic purification and reuse, utilizing L-tryptophan as a functional monomer with HEM and ETGMA for polymerization, enhancing binding efficiency and selectivity.
The nanomaterial enables fast, affordable, and high-purity purification of MeA and AMP, suitable for industrial use and as a selective element in diagnostic and biosensor systems, with high chromatographic separation power and biocompatibility.